Getting latest data loading
Home / Morning Report / Morning Report – 23rd October 2023

This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.

Morning Report - 23 October 2023

Yesterday’s UK 100 Leaders Price (p) % Chg
Endeavour Mining PLC 1,752.0 3.9%
Bae Systems PLC 1,064.5 2.3%
Convatec Group PLC 200.4 2.1%
Mondi PLC 1,269.5 1.4%
Unite Group PLC 866.0 0.9%

 

Yesterday’s UK 100 Laggards Price (p) % Chg
Ocado Group PLC 475.9 -5.2%
Rentokil Initial PLC 459.4 -5.1%
Anglo American PLC 2,063.5 -4.3%
HSBC Holdings PLC 617.0 -3.8%
Intercontinental Hotels Group PLC 5,934.0 -3.6%

 

Major World Indices Price % Chg 1 YEAR
UK 100 INDEX 7,396 -1.4% 6.7%
DOW JONES INDUS. AVG 33,263 -0.5% 9.6%
DAX INDEX 14,826 -1.5% 16.1%
NIKKEI 225 31,259 -0.5% 16.3%
S&P/ASX 200 INDEX 6,901 -1.2% 3.4%
Commodities Units Price % Chg
WTI Crude Oil (Nymex) USD/bbl. 90.15 0.87%
Brent Crude (ICE) USD/bbl. 93.38 1.08%
Gold Spot USD/t oz. 1,991 0.8%
Copper (Comex) USd/lb. 357 -0.8%
The UK 100 called to open +7 points at 7,409

4 hours; 3 Months

Click graph to enlarge

Markets Overview:

The UK 100 called to open +7 points at 7,409.  The UK 100 is expected to make a muted start as events in the Middle East continue to spark nerves and ahead of earnings from some of the leading names of the business world.  Stocks retreated Friday as a surge in the 10-year Treasury yield bonds prompted broader concerns about the state of the economy.  The S&P shed 1.26% to finish the week at 4,224.16 and registered its first losing week in three. The Nasdaq dropped 1.53% to end at 12,983.81. The Dow Jones Industrial Average lost 286.89 points, or 0.86%, to end at 33,127.28, dragged down in the session by American Express following a mixed earnings report.

 

 

Company News & Broker Comments:

Company News:

AstraZeneca, Daiichi Sankyo’s Enhertu approved in EU for HER-2 mutant lung cancer.

 

 

Indivior will pay $385m to settle a lawsuit brought by direct purchasers on claims it illegally supressed generic competition for its opioid addiction treatment Suboxone.

 

 

Vistry says they are aiming for an adjusted pretax profit of £450m for FY23 as they expect a £40m impact of reduction in site margins in FY23.

 

Broker Comments:

Jefferies Upgrades Tullow Oil to Hold from Underperform (4 Buys / 2 Holds / 1 Sell)

Reporting Today:

UK

 

None

 

 

 

US

 

None

Reporting Tomorrow:

UK

 

Anglo American

Barclays

Bunzl

Softcat

Travis Perkins

W.A.G Payment Solutions

 

 

US

 

3M Co

Coca-Cola

General Electric

General Motors

Spotify Technology SA

Verizon Communications

Alphabet Inc C

Alphabet Inc A

Microsoft Corp

Snap Inc A

Teladoc Health

Visa Inc Class A

 

 

In Focus Today:

German Buba Monthly Report

EU Consumer Confidence

 

This Week’s Ex-Dividends:

UK 250 companies going ex-dividend on 26th October 2023:

 

Dunelm Group

Morgan Advanced Materials

Sequoia Economic Infrastructure Inc Fnd

City of London Investment Trust

Balfour Beatty

Bankers Investment Trust

Pacific Horizon Investment Trust

For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.


Back to Top

This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.


Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.

Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 67% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.
.